The cDNAs encoding venom phospholipase A 2 (PLA 2 ) inhibitors (PLIs), named Protobothrops elegans (Pe)-PLI-A, PePLI-B, PePLI-A, and PePLI-B, were cloned from the P. elegans liver cDNA library. They were further divided into several constituents due to nucleotide substitutions in their open reading frames. For PePLI-A, two constituents, PePLI-A a and Pe-PLI-A b , were identified due to three nonsynonymous substitutions in exon 3. Far-western blot and massspectrometry analysis of the P. elegans serum proteins showed the presence of PLIs, and PLIs, which can bind venom PLA 2 s. In PLIs from Protobothrops sera, A or B subtype-specific amino acid substitutions are concentrated only in exon 3. A comparison of PLIs showed that PLI-As are conserved and PLI-Bs diversified. Mathematical analysis of the nucleotide sequences of Protobothrops PLI-B cDNAs revealed that the particular loops in the three-finger motifs diversified by accelerated evolution. Such evolutionary features should have made serum PLIs acquire their respective inhibitory activities to adapt to venom PLA 2 isozymes.
The sera of many venomous snakes contain inhibitory factors to neutralize toxic proteins in their own venoms. These proteins are expected to work defensively on the occasion of an accidental bite by a snake of the same species. Phospholipase A 2 (PLA 2 ) [EC 3.1.1.4] inhibitors (PLIs), are the most investigated inhibitory factors among these. The sera of some nonvenomous snakes are also known to contain PLIs. [1] [2] [3] PLA 2 catalyzes the hydrolysis of the 2-acyl ester bond of 3-sn-glycerophospholipids, with the requirement of Ca 2þ . 4, 5) Snake venoms contain PLA 2 isoforms as major toxic components. Snake venom PLA 2 s are classified into groups I and II based on the mode of disulfide pairing. 6 7, 8) They share the same scaffold. [9] [10] [11] [12] The PLA 2 isozymes of Protobothrops flavoviridis (Pf) (Crotalinae) (Amami-Oshima, Tokunoshima, and Okinawa Islands of Japan) have been well studied, 13) and are classified into four types depending on primary structures and physiological functions. 14) It is well known that their genes evolved via Darwinian-type accelerated evolution to acquire diverse physiological activities. [15] [16] [17] [18] [19] 2) and PeBP(R)-II (pI 9.3), were identified in the venom of Protobothrops elegans (Pe) (Crotalinae), which inhabits the Sakishima Islands, Japan, located between Okinawa and Taiwan. 20) PeBP(R)-I and PeBP(R)-II were 81-82% similar in sequence to BPI 21) and BPII 22) of P. flavoviridis venom, which are categorized as [Lys 49 ]PLA 2 . They consist of 121 amino acid residues, in contrast to other PLA 2 isozymes of Protobothrops genus, with 122 amino acid residues. The evolutionary difference in venom PLA 2 isozymes between P. elegans and P. flavoviridis appears to be related to the geological history of the islands where they live. After the ancestor of the Protobothrops genus divided into two groups, possibly 1.8-1.0 million years ago, one group remained in Amami-Ohshima, Tokunoshima, and Okinawa, and the other settled in the Sakishima Islands and Taiwan. 23, 24) The former is considered to have evolved into P. flavoviridis and the latter into P. elegans. 20) Many PLIs have been isolated from various snake sera, and their primary structures have been determined.
3) They are classified into three types, PLI, PLI, and PLI, based on their primary structures and affinities to different PLA 2 s. Furthermore, and PLIs are divided into two subtypes, A and B, referring to the primary y To whom correspondence should be addressed. Tel: +81-96-326-3984; Fax: +81-96-323-1331; E-mail: chijiwa@life.sojo-u.ac.jp Abbreviations: ACN, acetonitrile; Cam, S-carboxamidomethyl; HPLC, high performance liquid chromatography; HRP, horse radish peroxidase; K A , number of nonsynonymous nucleotide substitutions per site; K S , number of synonymous nucleotide substitutions per site; MS, mass spectrometry; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; Pe, Protobothrops elegans; Pf, Protobothrops flavoviridis; PLA 2 , phospholipase A 2 ; PLI, phospholipase A 2 inhibitor; SDS, sodium dodecyl sulfate; TFA, trifluoroacetic acid; UTR, untranslated region structures and the modes of disulfide pairing. Four PLIs, named PLI-A (or PLI-IV), PLI-B (or PLI-V), PLI-I, and PLI-II, have been fractionated from Tokunoshima P. flavoviridis sera and analyzed. 25, 26) PLI-A and PLI-B, which showed 90% similarity to each other, belong to the PLI family. They are now called PLI-A and PLI-B respectively. 27) Here we call them PfPLI-A and PfPLI-B respectively. They are glycoproteins composed of 166 amino acid residues including a signal peptide of 19 amino acid residues, and have a C-type lectin-like carbohydrate-recognition domain and inhibit group-II acidic PLA 2 . 25, 28, 29) Amino acid substitutions in the N-terminal one-third portion between them are concentrated in the region encoded by exon 3 of their genes. 30) Most of them are nonsynonymous substitutions, possibly relating to binding specificities against PLA 2 isozymes. PLI-I and PLI-II, which are now called PLI-A (or PfPLI-A) and PLI-B (or PfPLI-B) respectively, 27) are glycoproteins composed of 200 amino acid residues including a signal peptide of 19 amino acid residues. Although the identity of the mature proteins of PfPLI-A and PfPLI-B is 30%, the positions of 16 half-cystine residues are conserved except for the presence of two additional half-cystine residues in PfPLI-B. They have two repeats of the three-finger motif characterized as the Cys/loop framework in the molecules. Such characteristic structures have also been found in urokinase-type plasminogen activator receptor (uPAR), 31) ly-6, 32) CD59, 33) neurotoxins, 34) and several proteins of unknown function in mammals. 27) In the present work, PLIs in P. elegans serum were investigated in terms of their structures, functions, and evolution. The cDNAs encoding PePLIs and PePLIs were cloned from the P. elegans liver cDNA library and sequenced. From the nucleotide substitutions in the open reading frames (ORFs) of their cDNAs, they were further separated into A and B subtypes and their constituents: PePLI-As into PePLI-A a , PePLI-A b , and PePLI-A c ; PePLI-Bs into PePLI-B a and Pe-PLI-B b ; PePLI-As into PePLI-A a and PePLI-A b ; and PePLI-Bs into PePLI-B a , PePLI-B b , PePLI-B c , and PePLI-B d . Far-western blotting and mass spectrometry (MS) analyses confirmed the presence of PLIs and PLIs in the P. elegans serum and their binding capability to PLA 2 isozymes. Examination of the amino acid sequences of PLIs from P. elegans and P. flavoviridis revealed that there were A subtype or B subtype-specific amino acid substitutions only in the region encoded by exon 3. A comparison of the amino acid sequences of PLI-As and PLI-Bs, which consist of anterior and posterior three-finger motifs, showed that PLI-As are conserved but PLI-Bs are diversified. It became evident that the diversity of PLI-Bs was brought about by accelerated evolution. Due to such evolutionary features, serum PLIs are expected to have acquired their varying inhibitory activities in a manner to adapt to venom PLA 2 isozymes, which have evolved in an accelerated manner.
Materials and Methods
Materials. P. elegans snakes were collected in the Sakishima Islands. Restriction endonucleases and Taq DNA polymerase were from Nippon Gene (Tokyo) and Promega (Tokyo) respectively. Specific oligonucleotide primers were synthesized by Hokkaido System Science (Sapporo, Japan). Total RNAs were extracted from P. elegans liver, and mRNAs were purified with a Nucleo Trap mRNA Midi Kit (Macherey-Nagel, Duren, Germany). All other reagents used were of the purest grade available.
Construction of P. elegans liver cDNA library. A cDNA library was constructed by the protocol of the SMART cDNA Library Construction Kit (Clontech, Palo Alto, CA) for mRNAs extracted from the P. elegans liver. The cDNAs were ligated to pTriplEx2 vector (Clontech, 1:6 Â 10 6 primary recombinant) and transduced into E. coli strain XL1-Blue.
Preparation of PePLI-A cDNAs from the P. elegans liver cDNA library. Sense primer (5 0 -AAACTCTCGCTCATGTGACTTN-3 0 where N ¼ G, A, T, and C, SHU1) and antisense primer (5 0 -GGCGTCCTTACATTCAACTTTN-3 0 , SHU2), which correspond to amino acid residues 17-24 and 185-193 respectively of the PfPLI-A protein, 27) were synthesized and employed in PCR against P. elegans liver firststrand cDNAs as template. The amplified 532 bp DNA fragment was used for screening of the liver cDNA library by the plaque hybridization method. 35) The phage clones obtained were converted to plasmid clones, pTriplEX2, by Cre-lox-mediated subcloning in E. coli strain BM25.8. The DNA fragments were labeled with digoxigenin (DIG) DNA Labeling Mix and Anti-DIG-AP (Roche, Mannheim, Germany). The nucleotide sequences were determined by the dideoxy chain termination method.
36) The sequence data reported are available at the DDBJ/EMBL/GenBank databases under accession nos. AB559507-AB559509.
Preparation of PePLI-B cDNAs from the P. elegans liver cDNA library. The screening method described for PePLI-A cDNAs failed to obtain PePLI-B cDNAs. Hence, PCR amplification was employed. A sense primer (5 0 -ATCAATCACTTTGTTCTCCACN-3 0 , SHU25) and an antisense primer (5 0 -GCCTTGATGTGCAGTTATACN-3 0 , SHU26), which correspond to the 5 0 and 3 0 untranslated regions (UTRs) respectively of Gloydius (formerly Agkistrodon) blomhoffii siniticus PLI-B cDNA, 1) were synthesized, and a P. elegans liver cDNA library was used as template for PCR. The amplification conditions were 5 min at 94 C, 35 cycles of 30 s at 94 C, 30 s at 55 C, 30 s at 72 C, and an extension period of 7 min at 72 C (GeneAmp PCR System 9700, Applied Biosystems, Foster City, CA). Three PePLI-B cDNA clones were obtained. Due to nucleotide substitutions, they are divided into two constituents, PePLI-B a cDNA (one clone) and PePLI-B b cDNA (two clones). The sequence data reported are available at the DDBJ/EMBL/GenBank databases under accession nos. AB559510-AB559511.
Preparation of PePLI-B cDNAs from the P. elegans liver cDNA library. A sense primer (5 0 -CATGAGACAGATCCTGACGGN-3 0 , SHU3) and an antisense primer (5 0 -TTTCATCACAGGACGCA-GAGN-3 0 , SHU4), which correspond to amino acid residues 20-26 and 148-155 respectively of the PfPLI-B protein, 25) were prepared and employed in PCR against P. elegans liver firststrand cDNAs as template. The amplified 456-bp cDNA obtained was used for screening of the liver cDNA library by the plaque hybridization method. The phage clones obtained were treated as described for the preparation of PePLI-A cDNAs. The sequence data reported are available at the DDBJ/EMBL/GenBank databases under accession nos. AB559512-AB559515.
Preparation of two overlapping PePLI-A cDNA segments from the P. elegans liver cDNA library. The method described for the cloning of PePLI-B cDNAs was unsuccessful in the preparation of PePLI-A cDNAs. In addition, semi-quantitative reverse transcription PCR indicated that the expression level of PePLI-A mRNA is too low compared to that of PePLI-B mRNA (data not shown). For the reason, with attention to the substitutions concentrated in exon 3 between the PfPLI-A and PfPLI-B genes 30) and the identical sequences of the 5 0 and 3 0 UTRs of their cDNAs, two segments were amplified by PCR of the P. elegans liver cDNA library with the primers designed as follows: The first combination is the 5 0 UTR sequence (5 0 -TCTAGAACAGCAGAAAGCACN-3 0 , SHU19) and the 3 0 downstream cDNA sequence of exon 3 (5 0 -GCATATCTCAGGT-GGGCATA-3 0 , SHU29, corresponding to residues 43-49), and the second is the 5 0 upstream cDNA sequence of exon 3 (5 0 -TCGAT-GATTGAAACCCTAATGTTT-3 0 , SHU27, corresponding to residues 31-38) and the 3 0 UTR sequence (5 0 -CTCTTTCAGCAGACCATG-CAN-3 0 , SHU20). The first combination of the primers gave six clones with the same sequence, and the second combination gave two clones with the identical sequence. They constituted the first and second halves of PePLI-A cDNAs, and were named the front (F) and rear (R) segments respectively (see Fig. 2B ). The sequence data reported are available at the DDBJ/EMBL/GenBank databases under accession nos. AB559516-AB559517.
Purification of the PLIs from the P. elegans serum. Blood (11 mL) from the P. elegans snakes was allowed to stand overnight at 4 C. After centrifugation, the supernatant was brought to 30% saturation of ammonium sulfate and left overnight at 4 C. After centrifugation, the supernatant was brought to 50% saturation of ammonium sulfate and left overnight at 4 C. The precipitate was dissolved in water, dialyzed against water, and lyophilized (386 mg). The proteins (250 mg) were dissolved in 50 mM Tris/HCl pH 7.5, and applied to a DEAEToyopearl 650M column equilibrated with the same buffer. Stepwise elution was done with the same buffer containing 0, 0.1, 0.2, and 1.0 M NaCl. The proteins eluted at 0.2 M NaCl weighed 70 mg, which is known to exhibit PLA 2 -inhibitory activity in the case of P. flavoviridis serum.
26) The aliquots (0.8 mg each) were further fractionated by reverse phase HPLC on a 5C18-AR-300 column (0:5 Â 15 cm) (Nacalai Tesque, Kyoto, Japan). The solvents were 0.1% trifluoroacetic acid (TFA) (A) and 80% acetonitrile (ACN) containing 0.02% TFA (B). Elution was carried out with a linear concentration gradient of solvent B from 0 to 100% for 60 min at a flow rate of 0.5 mL per min.
SDS-PAGE and amino acid sequence determination. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out by the method of Laemmli 37) under reducing conditions. The N-terminal amino acid sequences of the PLIs were analyzed on an Applied Biosystems ProciseÔ 471 protein sequencing system (Applied Biosystems). The sequences of the tryptic fragments of S-carboxamidomethylated PLIs were analyzed by MS, as described below.
Far-western blotting analysis. The HPLC-eluted fractions containing P. elegans serum PLIs underwent SDS-PAGE, and the proteins were transferred onto nitrocellulose membrane. The membrane was incubated in blocking buffer (PBS(À) containing 1% Tween 20 and 2.5% skim milk) for 1 h and immersed in PBS-T (PBS(À) containing 1% Tween 20) for 5 min. PLA 2 isozymes from P. flavoviridis venom, PLA2 38) and BPI, were employed as probes because they are abundant and are regarded as representatives of Protobothrops genus venom [Asp 49 ]PLA 2 s and [Lys 49 ]PLA 2 s respectively. They were dissolved in PBS-T to a final concentration of 0.5 mg per mL and incubated with the membrane overnight at 4 C. The membrane was washed with PBS-T 2 times for 30 min to remove unbound PLA 2 isozymes. The membrane was then incubated with rabbit anti-PLA2 or anti-BPI antibodies diluted 1:10,000 with PBS-T overnight at 4 C. The primary antibody was removed and the membrane was washed with PBS-T 2 times for 10 min. The membrane was exposed to horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody at a 1:3,000 dilution for 1 h at room temperature. The secondary antibody was removed and the membrane was washed with PBS-T at room temperature 3 times for 10 min. Detection was conducted with an ECL western blot analysis system (GE Healthcare, Buckinghamshire, UK).
In-gel digestion. The bands of PLIs from fractions 3 and 8 on the SDS-PAGE gel (Fig. 4, upper panel) , which were stained with SimplyBlue (Invitrogen, Carlsbad, CA), were excised and in-gel digested with trypsin after reduction and S-carboxamidomethylation by the method described by Shevchenko et al.
39) The peptides were extracted from the gel with 50% ACN containing 5% TFA, and the extracts were evaporated down to 10 mL.
Mass spectrometry (MS).
The extracts of the tryptic in-gel digests of S-carboxamidomethylated (Cam) PLIs from fractions 3 and 8 (Fig. 4 , upper panel) were analyzed by nano-liquid chromatography electrospray MS (nano-LC/ESI/MSMS) using the QSTAR LC/MSMS System (Applied Biosystems/MDS SCIEX, Foster City, CA) equipped with a nanospray source and a nano-LC system (DiNA Splitless Nano HPLC System, KYA Tech, Tokyo). A C 18 nano-column was used, and the flow rate was 300 nL per min. Analysis was done in positive ion mode using rolling collision energy for optimum peptide bond fragmentation. Peptides were identified from the databases for P. flavoviridis and P. elegans using ProID software (Applied Biosystems/MDS SCIEX).
Evolutionary analysis of the PLI-Bs from the P. elegans and P. flavoviridis sera. For pairs of the nucleotide sequences of PePLI-B a (AB559510), PePLI-B b (AB559511), and PfPLI-B cDNAs (AB290845), 27 ) the numbers of nucleotide substitutions per synonymous site (K S ) and the numbers of nucleotide substitutions per nonsynonymous site (K A ) were computed for the regions corresponding to loops I, II, and III of the anterior and posterior three-finger motifs by the method developed by Nei and Kumar. 40) If the K A /K S values are greater than or close to unity, accelerated evolution can be assumed. 16, 17) 
Results and Discussion
Isolation of PePLI-A and PePLI-B cDNAs from the P. elegans liver cDNA library and their nucleotide sequences PLIs are regarded as the major PLA 2 inhibitors in snake sera. 3) In order to isolate the cDNA encoding PLI-A of the P. elegans serum, we screened the P. elegans liver cDNA library with a specific 532 bp DNA fragment, prepared as described in ''Materials and Methods.'' Due to nucleotide substitutions in their ORFs, 16 PLI-A positive clones were divided into three constituents: the cDNAs encoding PePLI-A a (10 clones), PePLI-A b (two clones), and PePLI-A c (one clone) (Fig. 1A) . They encoded 200-amino acid proteins including 19-amino acid signal peptides, and showed 98-99% identity against PfPLI-A. 30) All the positions of the half-cystine residues in the mature proteins were entirely identical among them. A potential glycosylation site was found at positions 157-159.
On the other hand, PCR against the P. elegans liver cDNA library with the primers corresponding to the two segments of the Gloydius blomhoffii siniticus PLI-B protein 1) (see ''Materials and Methods'') gave three clones encoding PePLI-Bs. Due to nucleotide substitutions, they were divided into two constituents, Pe-PLI-B a cDNA (one clone) and PePLI-B b cDNA (two clones) (Fig. 1B) . Both encoded 200-amino acid proteins including 19-amino acid signal peptides, and they showed 90% similarity to each other. The homologies of PePLI-B a and PePLI-B b against PfPLI-B are 92 and 89% respectively. 27) A potential glycosylation site was found only in PePLI-B b , at positions 14-16. All the positions of the half-cystine residues in the mature proteins were entirely identical among them.
Isolation of PePLI-B and PePLI-A cDNAs from the P. elegans liver cDNA library
In order to acquire cDNA encoding PLI-B of P. elegans serum, the P. elegans liver cDNA library was screened with the specific 456-bp DNA fragment (see ''Materials and Methods''). Nine positive clones were obtained, and all were identified as the B subtype. Due to nucleotide substitutions in their ORFs, these clones were divided into four constituents, the clones encoding PePLI-B a (four clones), PePLI-B b (three clones), PePLI-B c (one clone), and PePLI-B d (one clone) (Fig. 2A) . All of them encode 166-amino acid proteins including 19-amino acid signal peptides, and are about 89% identical against PfPLI-B.
30) All the positions of the half-cystine residues in the mature proteins were entirely identical among them. Two potential glycosylation sites were found, at positions 1-3 and 103-105.
To acquire the PePLI-A cDNAs, a novel strategy was employed. Two DNA segments, named F and R, which overlap in the region corresponding to exon 3 of the PfPLI-A gene, 30) were amplified by PCR of the P. elegans liver cDNA library with two combinations of primers, referring to the nucleotide sequence of the PfPLI-A cDNA, and were sequenced (see details in ''Materials and Methods''). The sequences of the regions corresponding to exon 3 of the F and R segments were different at positions 99, 103, and 112, which are nonsynonymous (Fig. 2B) . The consequent amino acid changes were I vs. M, T vs. A, and F vs. V at amino acid positions 33, 35, and 38 respectively. The sequence of the F fragment in this region was in accord with that of the corresponding region of PfPLI-A cDNA.
30) The cDNA clones with the same sequence as that of the R fragment in the exon 3 region were thought to be another constituent of PePLI-A. Hence they were named PePLI-A a and PePLI-A b respectively (Fig. 2B) . They encoded 166-amino acid proteins including 19-amino acid signal peptides. The identities of PePLI-A a and PePLI-A b against PfPLI-A were 89 and 91% respectively. 30) Two potential glycosylation sites were found, at positions 1-3 and 103-105.
Identification of PLI proteins in the P. elegans serum by a combination of far-western blotting and MS analysis P. elegans serum proteins precipitated at 50% saturation of ammonium sulfate were chromatographed on a DEAE-Toyopearl 650M column at pH 7.5 (50 mM Tris/ HCl), and were eluted stepwise with the same buffer containing 0, 0.1, 0.2, and 1.0 M NaCl (Fig. 3A) . The proteins were eluted at 0.2 M NaCl further fractionated by reverse phase HPLC, as shown in Fig. 3B . Farwestern blotting of nine fractionated proteins with PLA2 and BPI as probes showed that fractions 3 and 8 contained PLA 2 binding proteins (Fig. 4) .
Re-chromatography of fraction 3 ( Fig. 3) on reverse phase HPLC gave a single peak (Fig. 5 ) and a single band on SDS-PAGE, from which its molecular weight was estimated to be 27 kDa (Fig. 5, inset) . After deglycosylation with glycopeptidase, its molecular weight was reduced to 24 kDa (Fig. 5, inset) . The Nterminal 34-amino acid residue sequence of the fraction 3 protein was compatible with that of PePLI-A (Table 1 ), but N-terminal sequence determination of far-western blotting-positive 24 kDa protein derived from fraction 8 failed.
The 27 kDa protein from fraction 3 and the 24 kDa protein from fraction 8 were in-gel digested with trypsin after reduction and S-carboxamidomethylation, and the extracts were applied to an LC MS/MS apparatus. The masses were analyzed by ProID software to identify PLI proteins from the databases for P. elegans and P. flavoviridis. The deduced amino acid sequences of 11 peptides from the 27-kDa protein of fraction 3 accurately matched those of the corresponding segments of PePLI-A a , PePLI-A b , and PePLI-A c (Table 1) . Four Fractionated on a Reverse-Phase HPLC Column (Fig. 3B) . Nine fractionated proteins underwent SDS-PAGE (upper panel) and the proteins were transferred onto a nitrocellulose membrane. They were hybridized with PLA2 (middle panael) and BPI (lower panel) both from P. flavoviridis venom as probes, and subjected to immunoblotting with anti-PLA2 antibody (middle panel) and anti-BPI antibody (lower panel). The membrane was exposed to HRPconjugated anti-rabbit IgG antibody, and the spots were detected by the ECL western blot analysis system. peptide sequences were also seen in P. flavoviridis PLI-A. Hence it is judged that the 27-kDa protein from fraction 3 consists of PePLI-A a , PePLI-A b , and PePLI-A c . Although the structural differences among PePLI-A a (His-45 and His-134), PePLI-A b (His-45 and Asn-134), and PePLI-A c (Arg-45 and His-134) were not ascertained by MS, it is likely that PLI-As are major inhibitory proteins in P. elegans serum and that they bind plural venom PLA 2 isozymes. LC MS/MS analysis of 24-kDa protein of fraction 8 showed that five peptides were related to those of PePLI-Bs and that a further five peptides were related to those of PePLI-As and PePLI-Bs. Summarizing all the data related above, it is concluded that P. elegans serum contains two subtypes of PLI, PLI-A and PLI-B, and two subtypes of PLI, PLI-A and PLI-B.
Molecular evolution of the PLIs and PLIs from P. elegans serum
In a comparison of the amino acid sequences of the PLIs from the P. elegans and P. flavoviridis sera, it was found that there were amino acid substitutions between them in the region encoded by exon 3 (Fig. 6) . 30) These were M18T, K22E, Y24I, and N36K (marked with asterisks), where the amino acids preceding the position numbers are those for the A subtypes, PePLI-A a , PePLI-A b , and PfPLI-A, and those following the position numbers are those for the B subtypes, PePLI-B a , PePLI-B b , PePLI-B c , PePLI-B d , and PfPLI-B. We call such substitutions subtypespecific. It is known that the exon 3 region evolved in an accelerated manner between the A and B subtypes of PfPLI.
30) It appears that the divergence in exon 3 is related to binding affinities to the PLA 2 isozymes.
P. flavoviridis PLIs are composed of anterior and posterior three-finger motifs. 26, 27) The intramolecular disulfide pairings in the three-finger motifs are expected to be identical to those in three-finger motifs of Homo sapiens urokinase-type plasminogen activator receptor (uPAR) 31) because of the similarity in the positions of the half-cystine residues. If this is true, it is generally thought that the sequences of the loop regions between the conserved half-cystine residues with low sequence similarity are closely related to their functions. The nucleotide sequences and the corresponding amino acid sequences of loops I, II, and III of the anterior and posterior domains in the three-finger motifs of the PLIAs (PePLI-A a , PePLI-A b , PePLI-A c , and PfPLI-A) and the PLI-Bs (PePLI-B a , PePLI-B b , and PfPLI-B) from the P. elegans and the P. flavoviridis sera were compared. Although most of substitutions were seen at nonsynonymous sites, there are apparently different patterns between the A and B subtypes. PLIAs are highly conserved, with only a few substitutions (data not shown). On the other hand, frequent substitutions were noted in the PLI-Bs, particularly in loops I and II of the anterior domain and loops II and III of the posterior domain (Fig. 7) . Although PLI-B-like proteins have been found in mammalian sources, 27) PLIAs, which lack a specific disulfide bond in their posterior three-finger motifs, are specific to snakes. It is likely that PLI-As are derived from ancestral PLI-B but are poorly diversified. Mathematical analysis of the nucleotide sequences of PePLI-B a , PePLI-B b , and PfPLI-B cDNAs showed that the K A /K S values were greater than or close to unity in loops I and II of the anterior domain and loops II and III of the posterior domain of the threefinger motifs ( Table 2 ), suggesting that these portions evolved in an accelerated manner, possibly acquiring particular inhibitory functions. Okumura et al. 41) and Dunn and Broady 3) reported that PLI forms a heterotrimer with two PLI-As and one PLI-B. The swapping of PLI-B and another PLI-B in the heterotrimer might explain the broad inhibitory activities of PLIs against various venom PLA 2 s. 
